Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: An explorative study

Psychosomatic Medicine

Volumn 60, Issue 5, 1998, Pages 543-549

  Dudok DeWit, A C ^a,b   Duivenvoorden, H J ^a   Passchier, J ^a   Niermeijer, M F ^a   Tibben, A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Genetic counseling; Hereditary cancer syndromes; Neurodegenerative disorders; Predictive DNA test

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CARRIER; DISTRESS SYNDROME; DNA DETERMINATION; FAMILIAL POLYPOSIS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MALE; OVARY CANCER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

EID: 0031711949     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199809000-00005     Document Type: Article

References (60)

1. Gusella JF, Wexler NS, Conneally PM, et al: A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:234-238, 1983
2. Bloch M, Adam S, Wiggins S, et al: Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk. Am J Med Genet 42:499-507, 1992
3. Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet 54:167-173, 1994
4. Codori AM, Brandt J: Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet 54:174-184, 1994
5. Decruyenaere M, Evers-Kiebooms G, Boogaerts A, et al: Predictive testing for Huntington's disease: Risk perception, reasons for testing and psychological profile of test applicants. Genet Couns 6:1-13, 1995
6. Evers-Kiebooms G, Swerts A, Van Den Berghe H: Partners of Huntington patients: implications of the disease and opinions about predictive testing and prenatal diagnosis. Genet Couns 1:151-159, 1990
7. Huggins M, Bloch M, Wiggins S, et al: Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 42:508-515, 1992
8. Quaid KA: Presymptomatic testing for Huntington disease in the United States. Am J Hum Genet 53:785-787, 1993
9. Quaid KA, Wesson MK: Exploration of the effects of predictive testing for Huntington disease on intimate relationships. Am J Med Genet 57:46-51, 1995
10. Simpson SA, Harding AE: Predictive testing for Huntington's disease: After the gene. The United Kingdom Huntington's Disease Prediction Consortium. J Med Genet 30:1036-1038, 1993
11. Tibben A, Frets PG, van de Kamp JJ, et al: On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet 48:103-111, 1993
12. Tibben A, Duivenvoorden HJ, Niermeijer MF, et al: Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom Med 56:526-532, 1994
13. Tibben A, Timman R, Bannink EC, et al: 3-Year follow-up after presymptomatic testing for Huntington Disease in tested individuals and partners. Health Psychol 16:20-35, 1997
14. Wiggins S, Whyte P, Huggins M, et al: The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med 327:1401-1405, 1992
15. Brook JD, McCurrach ME, Harley HG, et al: Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808, 1992
16. Bird TD. Familial Alzheimer's disease. Ann Neurol 36:335-336, 1994
17. Haltia M, Viitanen M, Sulkava R, et al. Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description. Ann Neurol 36:362-367, 1994
18. Bakker E, van Broeckhoven C, Haan J, et al. DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 49:518-521, 1991
19. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
20. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
21. Kinzler KW, Nilbert MC, Su LK, et al: Identification of FAP locus genes from chromosome 5q21. Science 253:661-665, 1991
22. Groden J, Thliveris A, Samowitz W, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600, 1991
23. Wijnen J, Vasen H, Khan PM, et al: Seven new mutations in HMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56:1060-1066, 1995
24. Wells S Jr, Chi DD, Toshima K, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220:237-247, 1994
25. Petersen GM: Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann Med 26:205-208, 1994
26. Petersen GM, Boyd PA: Gene tests and counseling for colorectal cancer risks: Lessons from familial polyposis. J Natl Canc Inst Monogr 17:67-71, 1995
27. Walpole IR, Kool DA, Edkins T, et al: Genetic counseling and gene mutation analysis in familial adenomatous polyposis in Western Australia. Med J Aust 162:464-467, 1995
28. Lerman C, Marshall J, Audrian J, et al: Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 69:58-61, 1996
29. Grossfeld FJM, Lips CJM, ten Kroode HFJ, et al: Psychological consequences of DNA analysis for MEN type 2. Oncology 10:141-146, 1996
30. Lynch HT, Watson P, Conway TA, et al. DNA screening for breast/ovarian cancer susceptibility based on linked markers: A family study. Arch Intern Med 153:1979-1987, 1993
31. Watson M, Lloyd SM, Eeles R, et al: Psychological impact of testing (by linkage) for the BRCA1 breast cancer gene: an investigation of two families in the research setting. Psychooncology 5:233-239, 1996
32. Lerman C, Narod S, Schulman K, et al: BRCA1 Testing in families with hereditary breast-ovarian cancer. J Am Med Assoc 275:1885-1892, 1996
33. Ponder M, Green JM: BRCA1 testing: Some issues in moving from research to service. Psychooncology 5:223-232, 1996
34. Dudok deWit AC, Tibben A, Frets PG, et al. BRCA1 in the family: A case description of the psychological implications. Am J Med Genet 71:63-71, 1997
35. Bloch M, Fahy M, Fox S, et al: Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 32:217-224, 1989
36. Craufurd D, Dodge A, Kerzin-Storrar L, et al: Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 2:603-605, 1989
37. Meissen GJ, Mastromauro CA, Kiely DK, et al: Understanding the decision to take the predictive test for Huntington disease. Am J Med Genet 39:404-410, 1991
38. Simpson SA, Besson J, Alexander D, et al: One hundred requests for predictive testing for Huntington's disease. Clin Genet 41:326-330, 1992
39. Tibben A, Stevens M, der Wert GMWR, et al: Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral hemorrhage and hereditary Pick disease. J Med Genet 34:63-72, 1997
40. Dudok deWit AC, Tibben A, Duivenvoorden HJ, et al: Psychological distress in applicants of predictive DNA-testing for autosomal dominant inheritable late onset disorders. J Med Genet 34:382-390, 1997
41. Horowitz MJ, Wilner N, Kaltreider N, et al: Signs and symptoms of posttraumatic stress disorder. Arch Gen Psychiatry 37:85-92, 1980
42. Horowitz MJ, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
43. Harper P: Ethical issues in genetic testing for Huntington's disease: Lessons for the study of familial cancers. Dis Markers 10:189-193, 1992
44. Bonke B, Smorenburg JMJ, van der Ent CK, et al: Evidence of denial and item-intensity specificity in the state-trait anxiety inventory. Person Individ Diff 8:185-191, 1987
45. Tops CM-J. Presymptomatic DNA Diagnosis of Familial Adenomatous Polyposis. Thesis, State University of Leiden, 1996.
46. Tibben A, Frets PG, van de Kamp JJ, et al. Presymptomatic DNA-testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 48:10-16, 1993
47. Zilberg NJ, Weiss DS, Horowitz MJ: Impact of Event Scale: A cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol 50:407-414, 1982
48. Schwarzwald J, Solomon Z, Weisenberg M, et al: Validation of the impact of event scale for psychological sequelae of combat. J Consult Clin Psychol 55:251-256, 1987
49. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 2nd Edition. London, Lawrence Erlbaum, 1983
50. Brandt J, Quaid KA, Folstein SE, et al: Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. J Am Med Assoc 261:3108-3114, 1989
51. Meissen GJ, Myers RH, Mastromauro CA, et al: Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med 318:535-542, 1988
52. Tibben A, Vegter-van der Vlis M, Skraastad MI, et al. DNA-testing for Huntington's disease in The Netherlands: A retrospective study on psychosocial effects. Am J Med Genet 44:94-99, 1992
53. Kessler S, Bloch M: Social system responses to Huntington disease. Fam Process 28:59-68, 1989
54. Dudok deWit AC, Meijers-Heijboer EJ, Tibben A, et al: Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer. Lancet 344:197, 1994
55. van der Steenstraten M, Tibben A, Roos RA, et al: Predictive testing for Huntington disease: Nonparticipants compared with participants in the Dutch program. Am J Hum Genet 55:618-625, 1994
56. Tibben A: What is knowledge but grieving? On psychological effects of presymptomatic DNA-testing for Huntington's disease. Thesis, Erasmus University Rotterdam, 1993.
57. Sijmons RH, Sikkens EH, Grosfeld FJM. Presymptomatic DNA testing in MEN2A families: Practical counselling issues. In Muller HJ, Weber W (eds), Proceedings of the 2nd International Research Conference on Familial Cancer. Basel, Karger, 1996
58. Levitt AJ, Rodin G, Cohen Z, et al: Coping styles, psychopathology and intellectual performance in patients with familial adenomatous polyposis. Gen Hosp Psychiatry 14:61-68, 1992
59. Dudok deWit AC, Tibben A, Duivenvoorden HJ, et al: Distress in individuals facing predictive DNA-tetsing for autososmal dominant late-onset disorders: Comparing questionnaire results with in-depth interviews. Am J Med Genet 75:62-75, 1998
60. Shedler J, Mayman M, Manis M: The illusion of mental health. Am Psychologist 48:1117-1131, 1993